These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27637307)

  • 21. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Direct oral anticoagulants (DOAC) : practical guidance for daily prescription].
    Robert-Ebadi H; Fontana P; Boehlen F; Righini M
    Rev Med Suisse; 2016 Dec; 12(542):2102-2112. PubMed ID: 28700163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism.
    Comerota AJ; Ramacciotti E
    Am J Med Sci; 2016 Jul; 352(1):92-106. PubMed ID: 27432042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence.
    Bo M; Grisoglio E; Brunetti E; Falcone Y; Marchionni N
    Eur J Intern Med; 2017 Jun; 41():18-27. PubMed ID: 28343849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with the new oral anticoagulants for treatment of venous thromboembolism.
    Bacchus F; Schulman S
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):513-9. PubMed ID: 25717178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
    Korin J
    Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct oral anticoagulant dose selection: Challenging cases.
    Carlin S; Eikelboom JW
    J Thromb Haemost; 2021 Nov; 19(11):2680-2686. PubMed ID: 34558172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI; Jaffer IH
    Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonvitamin K antagonist oral anticoagulants in everyday practice: Stroke prevention in atrial fibrillation and treatment of venous thromboembolism.
    Bentz BA
    J Am Assoc Nurse Pract; 2015 Dec; 27(12):721-31. PubMed ID: 26676209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct-Acting Oral Anticoagulants in Critically Ill Patients.
    Rali P; Gangemi A; Moores A; Mohrien K; Moores L
    Chest; 2019 Sep; 156(3):604-618. PubMed ID: 31251908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations.
    van Es N; Büller HR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():125-31. PubMed ID: 26637711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Direct Oral Anticoagulants in Morbidly Obese Patients.
    Kido K; Lee JC; Hellwig T; Gulseth MP
    Pharmacotherapy; 2020 Jan; 40(1):72-83. PubMed ID: 31834939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism.
    Fanikos J; Burnett AE; Mahan CE; Dobesh PP
    Am J Med; 2017 Oct; 130(10):1137-1143. PubMed ID: 28687262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly].
    MMW Fortschr Med; 2011 Sep; 153(37):16. PubMed ID: 21950182
    [No Abstract]   [Full Text] [Related]  

  • 38. [New anticoagulants: better knowledge, better prescriptions].
    Boehlen F; de Moerloose P
    Rev Med Suisse; 2012 Jan; 8(324):96-9. PubMed ID: 23185817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Italian intersociety consensus on DOAC use in internal medicine.
    Prisco D; Ageno W; Becattini C; D'Angelo A; Davì G; De Cristofaro R; Dentali F; Di Minno G; Falanga A; Gussoni G; Masotti L; Palareti G; Pignatelli P; Santi RM; Santilli F; Silingardi M; Tufano A; Violi F; ; ;
    Intern Emerg Med; 2017 Apr; 12(3):387-406. PubMed ID: 28191610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants.
    Bavalia R; Middeldorp S; Weisser G; Espinola-Klein C
    Thromb Haemost; 2020 Jun; 120(6):899-911. PubMed ID: 32492723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.